347 results on '"Oortwijn, Wija"'
Search Results
2. How to strengthen societal impact of research and innovation? Lessons learned from an explanatory research-on-research study on participatory knowledge infrastructures funded by the Netherlands Organization for Health Research and Development
3. Cost-utility analysis of TAVI compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in the Netherlands
4. Lessons Learned From Clinical Studies in Centronuclear Myopathies: The Patient Perspective—A Qualitative Study
5. The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?
6. The experience of clinical study and trial participation in rare diseases: A scoping review of centronuclear myopathy and other neuromuscular disorders
7. Prioritization of COVID-19 vaccination. The added value of the “VALIDATE” approach
8. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
9. Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective.
10. The capability approach in rehabilitation: developing capability care
11. Mixed claims in Health Technology Assessment: The case of Non-Invasive Prenatal Testing
12. Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group - Author's reply
13. Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group – author’s reply
14. OP18 Laying The Foundation For Sustainable Health Technology Assessment Training Program In Ukraine
15. The experience of clinical study and trial participation in rare diseases: A scoping review of centronuclear myopathy and other neuromuscular disorders
16. OP102 Towards Universal Health Coverage: Health Technology Assessment Roadmap Development In The Emirate Of Abu Dhabi Involving The Whole Ecosystem
17. The Value of Diagnostic Information in Personalised Healthcare : A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems
18. Towards a Taxonomy of Logic Models in Systematic Reviews and Health Technology Assessments: A Priori, Staged, and Iterative Approaches
19. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward
20. The VALIDATE handbook : An approach on the integration of values in doing assessments of health technologies
21. Hospital-Based HTA at Radboud University Medical Centre in the Netherlands: Welcome to Reality
22. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries
23. Series: Clinical Epidemiology in South Africa. Paper 3: Logic models help make sense of complexity in systematic reviews and health technology assessments
24. Case-studies of displacement effects in Dutch hospital care
25. Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group
26. Role of Health Technology Assessment in Pharmaceutical Market Access in Developed Countries
27. Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group
28. The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan
29. Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach
30. The VALIDATE handbook
31. Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment : The Values in Doing Assessments of Health Technologies Approach
32. Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project
33. Lay and professional stakeholder involvement in scoping palliative care issues: Methods used in seven European countries
34. In Memoriam H. David Banta
35. 180:oral Designing health benefit packages for universal health coverage – should countries follow a sectoral, incremental or hybrid approach?
36. Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project
37. Response to redefining health technology assessment: a comment on “the new definition of health technology assessment: a milestone in international collaboration”
38. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
39. Health technology assessment: A matter of facts and values
40. Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide
41. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework
42. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
43. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
44. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
45. Core competencies for ethics experts in health technology assessment
46. Introduction
47. Ethics and HTA: some lessons and challenges for the future
48. Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe
49. Core competencies for ethics experts in health technology assessment
50. Problematic Notions in Dutch Health Care Package Decisions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.